Back to the library
Metabolic research
Tirzepatide
Human trialsResearch education only. This profile does not establish benefits or safety for personal use.
EvidenceHuman trials
Curated studies1
Research areaMetabolic research
At a glance
A GIP and GLP-1 receptor agonist evaluated in large randomized human studies of metabolic disease.
How it is studied
Acts at the GIP and GLP-1 receptors; outcomes depend on the studied population and specific medicinal product.
Evidence & studies 1 curated
Read the population, methods, and limitations alongside each outcome. This selection is a starting point, not a systematic review.
Human randomized trial · 2022Tirzepatide Once Weekly for the Treatment of Obesity
Read summary & limitationsRisks & limits
- Clinical benefit and long-term safety are not established by the evidence curated here.
- Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.
No universal storage, reconstitution, or administration protocol is provided. Product-specific instructions and evidence must be established separately.